The ABO blood group system and Plasmodium falciparum malaria
The ABO blood group system is arguably the best known, and yet the most functionally mysterious, genetic polymorphism in humans. In clinical practice, ABO is the most important system for blood group compatibility. In the century since their discovery, ABO antigen associations with infections and other diseases have been the subject of hundreds of publications.
1, 2 Some reports found unexpected associations, such as the susceptibility of group A individuals to salivary or gastric cancers. 3 However, associations with diseases affecting humans after reproduction are not expected to exert any genetic selection. Thus, despite a large body of literature, the evolutionary basis for the origin and diversity of ABO blood group antigens remains uncertain. Much new information has emerged since a relationship between ABO and malaria was first suggested over 40 years ago. 4 We review literature in support of the hypothesis that Plasmodium falciparum malaria has shaped the distribution of ABO blood groups in humans.
We offer four arguments in support of this hypothesis: first, we review evidence that P.
falciparum was present at the time when ABO polymorphisms arose. Second, we note that the current world-wide distribution of ABO groups is consistent with an effect from P. falciparum.
Third, we critically review studies examining clinical outcomes during P. falciparum infection.
Fourth, we offer proposed biologic mechanisms relating host ABO group to the pathophysiology and lethality of P. falciparum malaria.
PLASMODIUM FALCIPARUM: THE STRONGEST FORCE IN THE RECENT HISTORY
OF THE HUMAN GENOME P. falciparum has been called "the strongest known force for evolutionary selection in the recent history of the human genome." 5 The signature of P. falciparum has been its enormous toll on human life, especially children. Infectious diseases that kill children select for survival genes and effectively prevent transmission of genotypes unfavorable to survival. In the case of P.
falciparum, untreated children suffer a 20-fold higher case fatality rate than adults. Even today, the world-wide loss of human life is staggering, with almost all of the 1 -2.7 million annual deaths -one every 12 seconds -occurring among children under the age of 5.
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The ability of
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The co-evolution of humans and P. falciparum: Figure 1 shows the parallel co-evolution of P. falciparum and its human host. The four species of malaria which infect humans today (Plasmodium vivax, ovale, malariae, and falciparum)
arose from an ancestral form 200 million years ago. 7 P. falciparum's closest genetic relative, P reichenowi, which infects chimpanzees, diverged from P. falciparum 9-10 million years ago, around the time that pre-human species diverged from chimpanzees and great apes. 7 Thus, P.
falciparum long pre-dated the development of modern humans.
Figure 1:
Co-evolution of P. falciparum malaria and humans.
Modern humans, Homo sapiens, began to emerge in Africa ~ 200,000 years ago 8, 9 and developed during a period overlapping with the current genetic form of P. falciparum. 10 Humans During the period from 70,000 to 4,000 years ago, multiple human erythrocyte mutations associated with a survival advantage in P. falciparum infection are thought to have developed.
These include structural hemoglobinopathies (Hb S, Hb C), 12 quantitative hemoglobinopathies (the thalassemias), 13 membrane mutations (spherocytosis, elliptocytosis, ovalocytosis) 14 and enzymopathies (G6PD deficiency). 15 The prevalence of these malaria-selected mutations, as well as the pressure P. falciparum exerted on the distribution of blood groups, may have further increased 10,000 years ago when the death toll from P. falciparum is thought to have increased substantially. 16 This increase in prevalence likely resulted from agriculture, forest-clearing, and animal domestication, all of which promoted success of the Anopheles mosquito. As a result, the most intense malarial selection pressures were effectively applied to the human genome in the relatively compressed period of the last few millennia, coincident with the observed development of multiple adaptive erythrocyte mutations.
P. falciparum was present during genetic selection of group O alleles:
The evolutionary story of the ABO genes sits squarely within this malarial timeline. Among modern humans, the most common allele for group O (termed O01) is identical to the group A allele (A01) for the first 261 nucleotides, at which point a guanosine base is deleted, resulting in a frame-shift mutation which produces a premature stop codon and failure to produce a 
RELATIONSHIP BETWEEN ABO GROUPS AND THE SEVERITY OF MALARIA: A CRITICAL REVIEW OF THE LITERATURE
We critically reviewed literature published during the last 28 years which investigated the relationship between P. falciparum infection and ABO groups. Studies in humans published through January 2007 were identified using Medline searches, textbook citations, and the reference lists from retrieved articles. Search terms included "Plasmodium falciparum", "malaria", and "ABO". Related articles for relevant publications were also queried.
Although we found 22 reports that explored an association between ABO group and P. falciparum malaria, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [44] [45] [46] [47] there was no definitive study with adequate sample size investigating ABO group and survival from P. falciparum infection. We focused, therefore, on
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From studies that examined ABO group and severity of disease. The sample size of twelve studies was too small to ascertain variations in the distribution of the ABO blood groups. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] Eleven studies were flawed by absent or inappropriate control groups. 20, 22, [27] [28] [29] [30] [31] [33] [34] [35] 37 Several publications reported data on individuals unlikely to succumb to P. falciparum, including fifteen studies of individuals with asymptomatic infection / incidental parasitemia, mild infection, or infection of unspecified severity. 20, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Finally, many studies failed to report outcomes among the most informative cohort, children < 5 years old, who suffer the highest morbidity and mortality. Given the small sample sizes, the flaws in study design, and unspecified or absent focus on clinical severity, it is not surprising that these studies failed to identify any association between ABO groups and outcomes from P. falciparum infection.
Well-designed clinical studies of ABO and clinical severity of P. falciparum infection:
In contrast to the above reports, Nevertheless, this initial study is intriguing because it suggests that a group O survival advantage in P. falciparum infection may begin in utero during fetal development.
The definitive study to assess ABO groups and survival from infection with P. falciparum
has not yet been conducted. It will need to examine mortality, especially among pediatric patients, prior to the age of reproduction. In addition, because even a slight survival advantage for any blood group would accumulate over many generations, it should have a sufficient sample size to detect a small effect, analyze outcomes separately for A, B, O and AB, and control for other phenotypes known to be associated with malaria survival. Currently, the best available studies, [44] [45] [46] [47] listed in Table 2 53 and/or to platelets ("heterotypic RBC rosettes").
54
Sequestration and rosette formation impair blood flow, causing tissue ischemia and cell death. 55 Not surprisingly, in-vitro rosetting is more pronounced in parasite strains derived from patients with severe disease, particularly in cases of cerebral malaria.
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Figure 2: The PfEMP-1 molecule, protein domains, and gene structure.
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The cartoon at the top indicates that PfEMP-1 contains both a CD36-binding domain and a lectin-like binding domain. This depiction is used in Figure 3 and Figure 4 . Figures 3 and 4 we highlight known and proposed mechanisms by which ABO exerts its influence. The binding of parasitized RBCs to group A and B determinants on endothelial cells 65 has not yet been demonstrated experimentally but would be expected to contribute to cytoadherence. As proposed in Figure 3 , such adherence may involve not only blood group antigens on endothelial cells, but also antigens present on platelets or von Willebrand's factor.
Lectin-like binding of parasitized erythrocytes with non-O blood group antigens:
Whether or not P. falciparum has selected for individuals with weak sub-groups of A or B and whether such individuals have improved survival during P. falciparum infection is unknown at this time and deserves further research. 
Disrupting rosettes with competitors of the lectin-binding domain of infected RBCs:
Further evidence supporting a role for group A or B antigens in rosetting comes from inhibition experiments. Tri-saccharides corresponding to the blood group A or B determinants reduced rosette formation from parasitized group A or B RBCs. 63, 64 In contrast, the monosaccharides were unable to disrupt rosettes. Given that soluble forms of group A and B antigen in plasma might reduce or disrupt rosette formation, higher plasma concentrations of these antigens might carry a selective advantage in P. falciparum malaria. See A individuals contained levels of group A glycoprotein >200 ng/mL in 5 of 9 sera, which was an order of magnitude higher than the levels seen in Le(a+b-) or Le(a-b+) subjects. 73 Recent evidence has shown that the selective pressure in favor of the Secretornegative phenotype likely results from protection afforded against viral gastrointestinal infections, which are known to cause lethal diarrhea in children. 75 In contrast, no explanation has yet emerged to account for a selective genetic pressure in favor of the Lewis-negative phenotype. Although the Le(b) antigen has previously been a suggested binding site for
Helicobacter pylori, 76 it is difficult to attribute any strong selective genetic pressure to this nonlethal bacterial infection. However, given the high levels of soluble blood group substance found in the plasma of Le(a-b-) Secretor-positive individuals and given the in vitro evidence that soluble blood group substances can disrupt malaria rosette formation, we offer the new hypothesis that P. falciparum may account for the three-fold higher prevalence of the Le(a-b-) phenotype among people of African ancestry. 77 For Thrombocytopenia is common in severe malaria and platelet localization to brain endothelium was found to be higher in children who died from cerebral malaria compared with uninfected coma controls. 88 The mechanism by which platelets promote adhesion of parasitized RBCs is not fully understood. A mechanism is proposed in Figure 4 . Central is the role of von Willebrand's factor (vWF). vWF function is directly related to ADAMTS13 activity and the vWF of group A individuals is more resistant to proteolysis by ADAMTS13 than that of group O individuals. shown that cerebral malaria is associated with increased levels of vWF pro-peptide. 90 vWF propeptide is released from endothelial storage sites in response to endothelial damage or activation by cytokines found in children with malaria. 91, 92 Although ADAMTS13 levels have not been measured in malaria, reduced hepatic release resulting from inflammation 94 would further enhance vWF-mediated platelet adhesion. In addition, reduced levels of nitric oxide (NO) likely contribute to the adhesive pathophysiology of malaria. Reduced NO promotes platelet activation and vWF-mediated adhesion, 95 and worsened survival in a rodent model of cerebral malaria. 96 Moreover, NO antagonists were observed to increase cytoadherence of parasitized cells to human endothelial cells under flow conditions in vitro. 97 Low levels of NO would be expected to occur in malaria as a result of arginase release during hemolysis and arginine deficiency from malnutrition. In fact, low arginine and low nitrite levels (an indirect marker of NO availability) were associated with the development of cerebral malaria in Tanzanian children. 98 Finally, multiple classes of cellular microparticles, including endothelial microparticles resulting from cell injury, platelet microparticles resulting from platelet activation, and RBC microparticles resulting from hemolysis, are likely to exert a pro-adhesive effect in the setting of active P.
falciparum infection. 99 Recently, microparticles have been described in malaria and to correlate with disease severity. 100, 101 Microparticles may worsen clinical outcomes in malaria not only by acting as small adhesive intermediates of heterotypic cellular adhesion, but also through tissue factor expression and procoagulant activity that generates thrombin, resulting in additional platelet activation. 102 Thus, multiple lines of evidence suggest that vWF may be central to heterotypic cell adhesion in malaria. As a result, the consistently lower levels of vWF found in group O subjects may provide an additional selection advantage among group O individuals infected with P. falciparum.
CONCLUSIONS
We have proposed that human and P. falciparum co-evolution has shaped the proportions of ABO antigens observed in humans across geographic regions. However, we recognize that the distribution of ABO has also been influenced by other events, 103, 104 including the migration of peoples with founder effects, population splitting from wars and famine, and other lethal pediatric diseases where survival may be associated with a specific ABO antigen.
For example, the possibility that the isohemagglutinins found in group O individuals provide broader immunity against various pathogens has been previously suggested. 105, 107 Our review of published data serves to emphasize the role of ABO in cytoadherence, rather than P. falciparum invasion of RBCs, which depends instead on glycophorin A. P.
falciparum thus contrasts with P. vivax, in which another particular blood group (Duffy) is essential to invasion.
Although our review highlights the reduced cytoadherence of P. falciparum among group O individuals, survival following infection is known to depend on a highly complex interaction between both host and parasite genes. 45, [108] [109] Indeed, the full extent of the selective pressure exerted by P. falciparum on the human genome has yet to be realized, and new examples of host survival genes continue to be discovered. Examples include recent evidence that a point mutation in the gene for nitric oxide synthetase provides as much protection against severe malaria as sickle cell trait, 110 or the discovery that the abca-1 gene deletion protects against cerebral malaria through reduced procoagulant microparticle generation. 111 Furthermore, because cell adhesion and malarial lethality also depend on parasite gene expression, the evolution of parasite genes has direct bearing on the selective pressure favoring different blood groups. Thus, the influence of P. falciparum infection on the relative proportion of ABO antigens is mutually complex.
Malaria is known to have affected many erythrocyte genes, including those concerned with globin synthesis, membrane proteins, and RBC enzymes. Given the importance of RBCs in malaria, an influence on genes encoding the most abundant antigens on the RBC membrane is not surprising. Our review suggests that P. falciparum was in the right position during evolutionary history to affect the origin and relative proportion of ABO antigens; that the geographic distribution of ABO antigens worldwide is consistent with a survival advantage in malaria among group O individuals; that clinical studies provide supporting evidence in favor of an effect of ABO group on disease severity; and that recent discoveries suggest biological mechanisms linking disease pathogenesis to ABO antigen expression. Taken together, these findings suggest that the evolution and distribution of ABO blood groups is linked to Plasmodium falciparum infection.
